Insulet | PODD - Ebit

金融业

USD

USD 2.99B

现金及等价物

USD 480.4M

USD 232.7M

USD 1.71B

USD 687.5M

USD 949.2M

USD 122M

USD 181.7M

3.9K

EPS每股收益

USD 1.42

股本和储备

USD 1.3B

USD 540.8M

债务利息支出

USD 14.7M

USD 5.7M

USD 929.5M

USD 11.56B

USD 91.1M

USD 639.7M

USD 122M

普通股股本

USD 69.26M

38.83

USD 113M

USD 761.7M

销售和管理费用

USD 317.2M

USD 462.5M

贸易债权人

USD 149.8M

应收帐款人

USD 544.7M

	Ebit	更改		日
Abbott	USD 2.13B		281M	2026-06
Align Technology	USD 191.32M		13.27M	2026-06
AtriCure	USD 9.66M		9.14M	2026-06
Avanos Medical	USD 8.9M		15.87M	2026-03
Baxter International	USD 276M		210M	2026-06
Becton, Dickinson and Co.	USD 627M		36M	2026-03
Boston Scientific	USD 1.24B		190M	2026-06
Cardinal Health	USD 861M		98M	2026-03
Cooper Companies	USD -31M		243.8M	2026-03
Dexcom	USD 318.3M		63M	2026-06
Edwards Lifesciences	USD 519.5M		4.8M	2026-06
Eli Lilly	USD 9.78B		792M	2026-03
Globus Medical	USD 164M		17.31M	2026-03
ICU Medical	USD 26.09M		770K	2025-12
Insulet	USD 122M		24.3M	2026-03
Integra LifeSciences	USD 41.29M		29.82M	2026-06
J&J	USD 7.48B		860M	2026-06
Medtronic	USD 2.09B		354M	2026-03
Merit Medical Systems	USD 60.4M		16.25M	2026-06
Roche Holding	CHF 11.46B		1.91B	2026-06
Solventum Corp	USD 85M		20M	2026-03
Stryker	USD 1.79B		687M	2026-06
Tandem Diabetes Care	USD 8.29M		31.16M	2025-12
Teleflex	USD 37.03M		686K	2026-03
West Pharmaceutical Services	USD 179.1M		2M	2026-06
Zimmer Biomet Holdings	USD 395.1M		92.2M	2026-03